Isolation and characterisation of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste

被引:197
作者
Sheih, I-Chuan [2 ]
Fang, Tony J. [2 ]
Wu, Tung-Kung [1 ]
机构
[1] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30068, Taiwan
[2] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan
关键词
Microalgae; Chlorella vulgaris; Hypertension; Angiotensin 1-converting enzyme; SPONTANEOUSLY HYPERTENSIVE-RATS; WAKAME UNDARIA-PINNATIFIDA; TRYPTIC HYDROLYSATE; FOOD PROTEINS; SYSTEM; IDENTIFICATION; SEQUENCE; DIGEST; SKIN;
D O I
10.1016/j.foodchem.2008.12.019
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A hendeca-peptide with angiotensin I-converting enzyme (ACE) inhibitory activity was isolated from the pepsin hydrolysate of algae protein waste, a mass-produced industrial by-product of an algae essence from microalgae, Chlorella vulgaris. Edman degradation revealed its amino acid sequence to be Val-Glu-Cys-Tyr-Gly-Pro-Asn-Ai-g-Pro-Gln-Phe. Inhibitory kinetics revealed a non-competitive binding made with IC50 Value against ACE of 29.6 mu M, suggesting a potent amount of ACE inhibitory activity compared with other peptides from the microalgae protein hydrolysates which have a reported range between 11.4 and 315.3 mu M. In addition, the purified hendeca-peptide completely retained its ACE inhibitory activity at a pH range of 2-10, temperatures of 40-100 degrees C, as well as after treatments in vitro by a gastrointestinal enzyme, thus indicating its heat- and pH-stability. The combination of the biochemical properties of this isolated hendeca-peptide and a cheap algae protein resource make an attractive alternative for producing a high value product for blood pressure regulation as well as water and fluid balance. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 26 条
  • [1] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN HYPERTENSION - POTENTIAL PROBLEMS
    ANTONIOS, TFT
    MACGREGOR, GA
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 : S11 - S16
  • [2] Byun HG, 2002, J BIOCHEM MOL BIOL, V35, P239
  • [3] CHEUNG HS, 1980, J BIOL CHEM, V255, P401
  • [4] DIFFERENTIAL-EFFECTS OF ORAL TRANDOLAPRIL AND ENALAPRIL ON RAT-TISSUE ANGIOTENSIN-CONVERTING ENZYME
    CHEVILLARD, C
    BROWN, NL
    MATHIEU, MN
    LALIBERTE, F
    WORCEL, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (01) : 23 - 28
  • [5] Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor
    Chiang, WD
    Tsou, MJ
    Tsai, ZY
    Tsai, TC
    [J]. FOOD CHEMISTRY, 2006, 98 (04) : 725 - 732
  • [6] SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG
    CUSHMAN, DW
    CHEUNG, HS
    [J]. BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) : 1637 - +
  • [7] ACE-inhibitory activity of probiotic yoghurt
    Donkor, O. N.
    Henriksson, A.
    Singh, T. K.
    Vasiljevic, T.
    Shah, N. P.
    [J]. INTERNATIONAL DAIRY JOURNAL, 2007, 17 (11) : 1321 - 1331
  • [8] Antioxidant activity of proteins and peptides
    Elias, Ryan J.
    Kellerby, Sarah S.
    Decker, Eric A.
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2008, 48 (05) : 430 - 441
  • [9] Fujita H, 2000, J FOOD SCI, V65, P564, DOI 10.1111/j.1365-2621.2000.tb16049.x
  • [10] Garnier J, 1996, METHOD ENZYMOL, V266, P540